FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/22/2024
Back to search
Official data from USPTO
SYNERPHAGE PRECISION BIOTECHNOLOGY. NATURAL DESIGN.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/22/2024
Trademark type
Combined
Nice classes
5, 40, 42
Filing date
06/27/2022
Registration date
01/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2024
Last transaction
01/09/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
09
Owner location
PL
Examiner
MAHMOUDI, MARIAM AZIZ
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a violet and purple rectangle having rounded corners with a violet and purple square having rounded corners connected in its upper left corner; the connected rectangle and square has a white border that is then outlined in violet and purple; the stylized white wording "SYNERPHAGE" appears within the rectangle above the stylized orange wording "Precision Biotechnology. Natural Design."; three interconnected outlines of white hexagons having orange, aquamarine and blue spots on their surface appears within the square.
Holders and representatives
Holders
Proteon Pharmaceuticals S.A.
Representatives
Alexander Lazouski Lazouski IP LLC
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment and prevention of bacterial infection or contamination and veterinary preparations for the treatment and prevention of bacterial infection or contamintaion; bacteriophages being bacteriological preparations for medical or veterinary purposes; pharmaceutical preparations based on bacteriophages for the treatment and prevention of bacterial infection or contamination and veterinary preparations based on bacteriophages for the treatment and prevention of bacterial infection or contamination
Class 40
Treatment of products and materials in the nature of waste wateranimal feeds and meat with bacteriophages; informationadvice and consultancy in relation to the aforesaid services
Class 42
Scientific research services; bacteriological research services related to bacteriophages and their culture and application; scientific research services in the fields of biologymicrobiologybacteriologybiotechnologypharmacymedicine and veterinary medicineagricultureanimal husbandryaquaculture and forestryfood and fodder production and preservationas well as soilwater and wastewater preservation; scientific testing and research services in the field of bacteriologybiotechnology; scientific and technological servicesscientific analysisscientific testing in the field of pharmaceuticals and veterinary medicine and research and design relating thereto; scientific design services for others in the field of pharmaceuticals and veterinary medicine; scientific research and development; research and development of new products for others in the field of bacteriophagestheir culture and application; research and development of new products for others in the fields of biologymicrobiologybacteriologybiotechnologypharmacymedicine and veterinary medicineagricultureanimal husbandryaquaculture and forestryfood and fodder production and preservationas well as soilwater and wastewater preservation; technical research in the field of pharmaceuticals and veterinary medicine; research relating to biological sciences; biological research; bacteriological research; bacteriological research on bacteriophages; informationconsultancy and advisory services relating to all the aforesaid services
Publications
History of USPTO decisions and trademark events.
29 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
04/12/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
04/12/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2024
GPNX
NOTIFICATION PROCESSED BY IB
10/31/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/24/2023
PUBO
PUBLISHED FOR OPPOSITION
10/24/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/06/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/15/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/15/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/15/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/15/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/31/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/30/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/30/2023
RFNT
REFUSAL PROCESSED BY IB
06/26/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/07/2023
RFRR
REFUSAL PROCESSED BY MPU
06/07/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/19/2023
CNRT
NON-FINAL ACTION WRITTEN
04/18/2023
DOCK
ASSIGNED TO EXAMINER
04/11/2023
MAFR
APPLICATION FILING RECEIPT MAILED
12/31/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/27/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/23/2022
Continuous trademark protection
Get notified about every new filing that threatens SYNERPHAGE PRECISION BIOTECHNOLOGY. NATURAL DESIGN. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.